BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 29617 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C18H16N4O/c1-12(2)18-21-20-15-9-8-14(10-22(15)18)17-16(19-11-23-17)13-6-4-3-5-7-13/h3-12H,1-2H3 GGUWFBJTYKFSCP-UHFFFAOYSA-N 16333 4-phenyl-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::CP-808844 Analog::triazolopyridine oxazole inhibitor 2 Mitogen-activated protein kinase 14 Homo sapiens 9.6 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16333&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9948405 46516574 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29618 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cccc(C)c1 InChI=1S/C19H18N4O/c1-12(2)19-22-21-16-8-7-15(10-23(16)19)18-17(20-11-24-18)14-6-4-5-13(3)9-14/h4-12H,1-3H3 LXNCCRGRUITJBS-UHFFFAOYSA-N 16334 4-(3-methylphenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::CP-808844 Analog::triazolopyridine oxazole inhibitor 3 Mitogen-activated protein kinase 14 Homo sapiens 18.3 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16334&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9944851 46516575 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29619 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C18H15FN4O/c1-11(2)18-22-21-15-8-5-13(9-23(15)18)17-16(20-10-24-17)12-3-6-14(19)7-4-12/h3-11H,1-2H3 OVCXRBARSPBVMC-UHFFFAOYSA-N 15414 6-[4-(4-Fluoro-phenyl)-oxazol-5-yl]-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine::Triazolopyridine deriv. 25::4-(4-fluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::CP-808844 Mitogen-activated protein kinase 14 Homo sapiens 5 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=15414&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 5289514 46515712 DB04797 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29620 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cccc(F)c1 InChI=1S/C18H15FN4O/c1-11(2)18-22-21-15-7-6-13(9-23(15)18)17-16(20-10-24-17)12-4-3-5-14(19)8-12/h3-11H,1-2H3 PPPKNNQINQHKNZ-UHFFFAOYSA-N 16335 4-(3-fluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 5 Mitogen-activated protein kinase 14 Homo sapiens 37.8 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16335 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16335&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23433744 46516576 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29621 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)c(C)c1 InChI=1S/C19H17FN4O/c1-11(2)19-23-22-16-7-5-14(9-24(16)19)18-17(21-10-25-18)13-4-6-15(20)12(3)8-13/h4-11H,1-3H3 QNWAANUBKXAVBR-UHFFFAOYSA-N 16336 4-(4-fluoro-3-methylphenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 6 Mitogen-activated protein kinase 14 Homo sapiens 6.6 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16336&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9902305 46516577 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29622 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(C)ccc1F InChI=1S/C19H17FN4O/c1-11(2)19-23-22-16-7-5-13(9-24(16)19)18-17(21-10-25-18)14-8-12(3)4-6-15(14)20/h4-11H,1-3H3 XFTMHZXWHNYWCM-UHFFFAOYSA-N 16337 4-(2-fluoro-5-methylphenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 7 Mitogen-activated protein kinase 14 Homo sapiens 4.3 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16337 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16337&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 20626557 46516578 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29623 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(Cl)cc1 InChI=1S/C18H15ClN4O/c1-11(2)18-22-21-15-8-5-13(9-23(15)18)17-16(20-10-24-17)12-3-6-14(19)7-4-12/h3-11H,1-2H3 XVXKYRDSRYOANW-UHFFFAOYSA-N 16338 4-(4-chlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 8 Mitogen-activated protein kinase 14 Homo sapiens 17.7 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16338&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23433741 46516579 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29624 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cccc(Cl)c1 InChI=1S/C18H15ClN4O/c1-11(2)18-22-21-15-7-6-13(9-23(15)18)17-16(20-10-24-17)12-4-3-5-14(19)8-12/h3-11H,1-2H3 KEAXLOURFDQQDT-UHFFFAOYSA-N 16339 4-(3-chlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 9 Mitogen-activated protein kinase 14 Homo sapiens 13.5 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16339&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23433778 46516580 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29625 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccccc1Cl InChI=1S/C18H15ClN4O/c1-11(2)18-22-21-15-8-7-12(9-23(15)18)17-16(20-10-24-17)13-5-3-4-6-14(13)19/h3-11H,1-2H3 VODQVPJIDAWTIW-UHFFFAOYSA-N 16340 4-(2-chlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 10 Mitogen-activated protein kinase 14 Homo sapiens 3.0 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16340 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16340&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647316 46516581 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29626 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1F InChI=1S/C18H14F2N4O/c1-10(2)18-23-22-15-6-3-11(8-24(15)18)17-16(21-9-25-17)13-5-4-12(19)7-14(13)20/h3-10H,1-2H3 YKVRZQFJVPFEAR-UHFFFAOYSA-N 16341 4-(2,4-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 11 Mitogen-activated protein kinase 14 Homo sapiens 4.6 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16341 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16341&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23433758 46516582 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29627 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)ccc1F InChI=1S/C18H14F2N4O/c1-10(2)18-23-22-15-6-3-11(8-24(15)18)17-16(21-9-25-17)13-7-12(19)4-5-14(13)20/h3-10H,1-2H3 UACOXBQBNWQWOK-UHFFFAOYSA-N 16342 4-(2,5-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 12 Mitogen-activated protein kinase 14 Homo sapiens 5.8 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16342 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16342&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9949821 46516583 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29628 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1c(F)cccc1F |(-5.34,-5.49,;-4.57,-4.15,;-3.03,-4.15,;-5.34,-2.82,;-6.87,-2.98,;-7.5,-1.57,;-6.35,-.54,;-6.35,1,;-5.02,1.77,;-3.69,1,;-3.69,-.54,;-5.02,-1.31,;-2.52,2,;-1.02,1.64,;-.22,2.96,;-1.22,4.13,;-2.64,3.53,;-3.97,4.3,;-3.97,5.85,;-2.64,6.62,;-5.31,6.62,;-6.64,5.85,;-6.64,4.3,;-5.31,3.53,;-5.31,1.99,)| InChI=1S/C18H14F2N4O/c1-10(2)18-23-22-14-7-6-11(8-24(14)18)17-16(21-9-25-17)15-12(19)4-3-5-13(15)20/h3-10H,1-2H3 VXRMIEYRPJSGLL-UHFFFAOYSA-N 16343 4-(2,6-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 13 Mitogen-activated protein kinase 14 Homo sapiens 14.6 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16343 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16343&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 22320671 46516584 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29629 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)c(F)c1 InChI=1S/C18H14F2N4O/c1-10(2)18-23-22-15-6-4-12(8-24(15)18)17-16(21-9-25-17)11-3-5-13(19)14(20)7-11/h3-10H,1-2H3 ZGGQRNYKRGMQPU-UHFFFAOYSA-N 16344 4-(3,4-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 14 Mitogen-activated protein kinase 14 Homo sapiens 22.3 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16344&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23433737 46516585 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29630 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)c(Cl)c1 InChI=1S/C18H14ClFN4O/c1-10(2)18-23-22-15-6-4-12(8-24(15)18)17-16(21-9-25-17)11-3-5-14(20)13(19)7-11/h3-10H,1-2H3 CTYRURASUKIBHM-UHFFFAOYSA-N 16345 4-(3-chloro-4-fluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 15 Mitogen-activated protein kinase 14 Homo sapiens 12.4 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16345&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23433783 46516586 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29631 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(Cl)cc1F InChI=1S/C18H14ClFN4O/c1-10(2)18-23-22-15-6-3-11(8-24(15)18)17-16(21-9-25-17)13-5-4-12(19)7-14(13)20/h3-10H,1-2H3 ZQDZBQZEDXQQPJ-UHFFFAOYSA-N 16346 4-(4-chloro-2-fluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 16 Mitogen-activated protein kinase 14 Homo sapiens 2.2 7.2000 30.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16346&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647317 46516587 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29632 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(Cl)ccc1F InChI=1S/C18H14ClFN4O/c1-10(2)18-23-22-15-6-3-11(8-24(15)18)17-16(21-9-25-17)13-7-12(19)4-5-14(13)20/h3-10H,1-2H3 AUKXECFBNFRGCT-UHFFFAOYSA-N 16347 4-(5-chloro-2-fluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 17 Mitogen-activated protein kinase 14 Homo sapiens 5.1 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16347&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647318 46516588 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29633 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1Cl InChI=1S/C18H14ClFN4O/c1-10(2)18-23-22-15-6-3-11(8-24(15)18)17-16(21-9-25-17)13-5-4-12(20)7-14(13)19/h3-10H,1-2H3 DSKANFBRGYWCHD-UHFFFAOYSA-N 16348 4-(2-chloro-4-fluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 18 Mitogen-activated protein kinase 14 Homo sapiens 2.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16348 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16348&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647319 46516589 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29634 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(Cl)c(F)c1 InChI=1S/C18H14ClFN4O/c1-10(2)18-23-22-15-6-4-12(8-24(15)18)17-16(21-9-25-17)11-3-5-13(19)14(20)7-11/h3-10H,1-2H3 AVYLKDHIHFEVPA-UHFFFAOYSA-N 16349 4-(4-chloro-3-fluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 19 Mitogen-activated protein kinase 14 Homo sapiens 43.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16349 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16349&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647320 46516590 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29635 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)c(F)c(F)c1 InChI=1S/C18H13F3N4O/c1-9(2)18-24-23-14-4-3-10(7-25(14)18)17-16(22-8-26-17)11-5-12(19)15(21)13(20)6-11/h3-9H,1-2H3 LSVSRXQCNHLTNR-UHFFFAOYSA-N 16350 5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-(3,4,5-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 20 Mitogen-activated protein kinase 14 Homo sapiens 4.1 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16350 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16350&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10043925 46516591 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29636 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)c(F)cc1F InChI=1S/C18H13F3N4O/c1-9(2)18-24-23-15-4-3-10(7-25(15)18)17-16(22-8-26-17)11-5-13(20)14(21)6-12(11)19/h3-9H,1-2H3 WAFVJSSWBCFXDX-UHFFFAOYSA-N 16351 5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-(2,4,5-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 21 Mitogen-activated protein kinase 14 Homo sapiens 3.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16351&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10473563 46516592 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29637 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1c(F)cc(F)cc1F |(-5.34,-5.49,;-4.57,-4.15,;-3.03,-4.15,;-5.34,-2.82,;-6.87,-2.98,;-7.5,-1.57,;-6.35,-.54,;-6.35,1,;-5.02,1.77,;-3.69,1,;-3.69,-.54,;-5.02,-1.31,;-2.52,2,;-1.02,1.64,;-.22,2.96,;-1.22,4.13,;-2.64,3.53,;-3.97,4.3,;-3.97,5.85,;-2.64,6.62,;-5.31,6.62,;-6.64,5.85,;-7.98,6.62,;-6.64,4.3,;-5.31,3.53,;-5.31,1.99,)| InChI=1S/C18H13F3N4O/c1-9(2)18-24-23-14-4-3-10(7-25(14)18)17-16(22-8-26-17)15-12(20)5-11(19)6-13(15)21/h3-9H,1-2H3 ZFXACTORXOHFRR-UHFFFAOYSA-N 16352 5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-(2,4,6-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 22 Mitogen-activated protein kinase 14 Homo sapiens 7.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16352&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10043924 46516593 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29638 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)cc(F)c1F InChI=1S/C18H13F3N4O/c1-9(2)18-24-23-14-4-3-10(7-25(14)18)17-16(22-8-26-17)12-5-11(19)6-13(20)15(12)21/h3-9H,1-2H3 SWLKWRLRWKYJKL-UHFFFAOYSA-N 16353 5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-(2,3,5-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 23 Mitogen-activated protein kinase 14 Homo sapiens 83.3 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16353&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10089749 46516594 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29639 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)c(F)c1F InChI=1S/C18H13F3N4O/c1-9(2)18-24-23-13-6-3-10(7-25(13)18)17-16(22-8-26-17)11-4-5-12(19)15(21)14(11)20/h3-9H,1-2H3 UVYJJMBRCLAQBP-UHFFFAOYSA-N 16354 5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-(2,3,4-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 24 Mitogen-activated protein kinase 14 Homo sapiens 11.1 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16354 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16354&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10361020 46516595 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29640 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C18H14Cl2N4O/c1-10(2)18-23-22-15-6-4-12(8-24(15)18)17-16(21-9-25-17)11-3-5-13(19)14(20)7-11/h3-10H,1-2H3 FXCMRYJIDRKZHH-UHFFFAOYSA-N 16355 4-(3,4-dichlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 25 Mitogen-activated protein kinase 14 Homo sapiens 26.4 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16355&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647321 46516596 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29641 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(Cl)cc1Cl InChI=1S/C18H14Cl2N4O/c1-10(2)18-23-22-15-6-3-11(8-24(15)18)17-16(21-9-25-17)13-5-4-12(19)7-14(13)20/h3-10H,1-2H3 IFDJWAPVRLGJTG-UHFFFAOYSA-N 16356 4-(2,4-dichlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 26 Mitogen-activated protein kinase 14 Homo sapiens 8.3 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16356&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647322 46516597 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29642 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cccc(Cl)c1Cl InChI=1S/C18H14Cl2N4O/c1-10(2)18-23-22-14-7-6-11(8-24(14)18)17-16(21-9-25-17)12-4-3-5-13(19)15(12)20/h3-10H,1-2H3 VBBYXLSNCXOMBB-UHFFFAOYSA-N 16357 4-(2,3-dichlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 27 Mitogen-activated protein kinase 14 Homo sapiens 14.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16357 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16357&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647323 46516598 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29643 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)c(Cl)cc1F InChI=1S/C18H13ClF2N4O/c1-9(2)18-24-23-15-4-3-10(7-25(15)18)17-16(22-8-26-17)11-5-14(21)12(19)6-13(11)20/h3-9H,1-2H3 QYULVPZCMUBANS-UHFFFAOYSA-N 16358 4-(4-chloro-2,5-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 28 Mitogen-activated protein kinase 14 Homo sapiens 24.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16358 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16358&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647324 46516599 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29644 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)c(F)cc1Cl InChI=1S/C18H13ClF2N4O/c1-9(2)18-24-23-15-4-3-10(7-25(15)18)17-16(22-8-26-17)11-5-13(20)14(21)6-12(11)19/h3-9H,1-2H3 DZOYLKSNBWXBCB-UHFFFAOYSA-N 16359 4-(2-chloro-4,5-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 29 Mitogen-activated protein kinase 14 Homo sapiens 5.6 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16359&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647325 46516600 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29645 CC(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)c(Br)c1 InChI=1S/C18H14BrFN4O/c1-10(2)18-23-22-15-6-4-12(8-24(15)18)17-16(21-9-25-17)11-3-5-14(20)13(19)7-11/h3-10H,1-2H3 MGWJKOIJCRUTRD-UHFFFAOYSA-N 16360 4-(3-bromo-4-fluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 30 Mitogen-activated protein kinase 14 Homo sapiens 8.0 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16360&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647326 46516601 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29646 CCc1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C17H14N4O/c1-2-14-19-20-15-9-8-13(10-21(14)15)17-16(18-11-22-17)12-6-4-3-5-7-12/h3-11H,2H2,1H3 GHTYLDSZYTWMCU-UHFFFAOYSA-N 16361 5-{3-ethyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-phenyl-1,3-oxazole::triazolopyridine oxazole inhibitor 31 Mitogen-activated protein kinase 14 Homo sapiens 54.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16361 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16361&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9965793 46516602 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29647 C1CC1c1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C18H14N4O/c1-2-4-12(5-3-1)16-17(23-11-19-16)14-8-9-15-20-21-18(13-6-7-13)22(15)10-14/h1-5,8-11,13H,6-7H2 YLYUFKWQQAJIFH-UHFFFAOYSA-N 16362 5-{3-cyclopropyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-phenyl-1,3-oxazole::triazolopyridine oxazole inhibitor 32 Mitogen-activated protein kinase 14 Homo sapiens 47.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16362 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16362&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9922441 46516603 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29648 C1CC(C1)c1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C19H16N4O/c1-2-5-13(6-3-1)17-18(24-12-20-17)15-9-10-16-21-22-19(23(16)11-15)14-7-4-8-14/h1-3,5-6,9-12,14H,4,7-8H2 FKFMKIWLJONUTR-UHFFFAOYSA-N 16363 5-{3-cyclobutyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-phenyl-1,3-oxazole::triazolopyridine oxazole inhibitor 33 Mitogen-activated protein kinase 14 Homo sapiens 16.6 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16363 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16363&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9944763 46516604 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29649 CCNc1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C17H15N5O/c1-2-18-17-21-20-14-9-8-13(10-22(14)17)16-15(19-11-23-16)12-6-4-3-5-7-12/h3-11H,2H2,1H3,(H,18,21) OYOWOBJJPQORTJ-UHFFFAOYSA-N 16364 N-ethyl-6-(4-phenyl-1,3-oxazol-5-yl)-[1,2,4]triazolo[3,4-a]pyridin-3-amine::triazolopyridine oxazole inhibitor 34 Mitogen-activated protein kinase 14 Homo sapiens 5.4 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16364 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16364&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647327 46516605 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29650 CCN(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C18H17N5O/c1-3-22(2)18-21-20-15-10-9-14(11-23(15)18)17-16(19-12-24-17)13-7-5-4-6-8-13/h4-12H,3H2,1-2H3 LSPZXWPKQKGQSA-UHFFFAOYSA-N 16365 N-ethyl-N-methyl-6-(4-phenyl-1,3-oxazol-5-yl)-[1,2,4]triazolo[3,4-a]pyridin-3-amine::triazolopyridine oxazole inhibitor 35 Mitogen-activated protein kinase 14 Homo sapiens 9.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16365 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16365&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647328 46516606 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29651 FC(F)c1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C16H10F2N4O/c17-15(18)16-21-20-12-7-6-11(8-22(12)16)14-13(19-9-23-14)10-4-2-1-3-5-10/h1-9,15H GIRBCCRJPRLVEE-UHFFFAOYSA-N 16366 5-[3-(difluoromethyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-phenyl-1,3-oxazole::triazolopyridine oxazole inhibitor 36 Mitogen-activated protein kinase 14 Homo sapiens 544 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16366&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23433767 46516607 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29652 FC(F)(F)Cc1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C17H11F3N4O/c18-17(19,20)8-14-23-22-13-7-6-12(9-24(13)14)16-15(21-10-25-16)11-4-2-1-3-5-11/h1-7,9-10H,8H2 GVSDOQWURSXBNP-UHFFFAOYSA-N 16367 4-phenyl-5-[3-(2,2,2-trifluoroethyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 37 Mitogen-activated protein kinase 14 Homo sapiens 83.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16367 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16367&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23433710 46516608 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29653 c1cc(on1)-c1nnc2ccc(cn12)-c1ocnc1-c1ccccc1 InChI=1S/C18H11N5O2/c1-2-4-12(5-3-1)16-17(24-11-19-16)13-6-7-15-21-22-18(23(15)10-13)14-8-9-20-25-14/h1-11H LOUVMERWKDIHEE-UHFFFAOYSA-N 16368 5-[3-(1,2-oxazol-5-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-phenyl-1,3-oxazole::triazolopyridine oxazole inhibitor 38 Mitogen-activated protein kinase 14 Homo sapiens 285 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16368 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16368&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 12113733 46516609 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29654 Fc1ccc(cc1)-c1ncoc1-c1ccc2nncn2c1 InChI=1S/C15H9FN4O/c16-12-4-1-10(2-5-12)14-15(21-9-17-14)11-3-6-13-19-18-8-20(13)7-11/h1-9H QYSDYIKAMYSXRZ-UHFFFAOYSA-N 16369 4-(4-fluorophenyl)-5-{[1,2,4]triazolo[3,4-a]pyridin-6-yl}-1,3-oxazole::triazolopyridine oxazole inhibitor 39 Mitogen-activated protein kinase 14 Homo sapiens 19.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16369 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16369&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647329 46516610 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29655 CCc1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C17H13FN4O/c1-2-14-20-21-15-8-5-12(9-22(14)15)17-16(19-10-23-17)11-3-6-13(18)7-4-11/h3-10H,2H2,1H3 HVGGHEUBVDQWKM-UHFFFAOYSA-N 16370 5-{3-ethyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(4-fluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 41 Mitogen-activated protein kinase 14 Homo sapiens 21.6 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16370 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16370&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9944440 46516611 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29656 CN(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C17H14FN5O/c1-22(2)17-21-20-14-8-5-12(9-23(14)17)16-15(19-10-24-16)11-3-6-13(18)7-4-11/h3-10H,1-2H3 AROFKXHYEPABPV-UHFFFAOYSA-N 16371 6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-N,N-dimethyl-[1,2,4]triazolo[3,4-a]pyridin-3-amine::triazolopyridine oxazole inhibitor 42 Mitogen-activated protein kinase 14 Homo sapiens 15.3 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16371 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16371&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 20626558 46516612 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29657 CCNc1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C17H14FN5O/c1-2-19-17-22-21-14-8-5-12(9-23(14)17)16-15(20-10-24-16)11-3-6-13(18)7-4-11/h3-10H,2H2,1H3,(H,19,22) IWELIULLJBIPIQ-UHFFFAOYSA-N 16372 N-ethyl-6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-[1,2,4]triazolo[3,4-a]pyridin-3-amine::triazolopyridine oxazole inhibitor 43 Mitogen-activated protein kinase 14 Homo sapiens 7.6 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16372 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16372&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647330 46516613 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29658 CCOc1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C17H13FN4O2/c1-2-23-17-21-20-14-8-5-12(9-22(14)17)16-15(19-10-24-16)11-3-6-13(18)7-4-11/h3-10H,2H2,1H3 AOYLIPWEHPGCGI-UHFFFAOYSA-N 16373 5-{3-ethoxy-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(4-fluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 44 Mitogen-activated protein kinase 14 Homo sapiens 55.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16373 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16373&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647331 46516614 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29659 Fc1ccc(cc1)-c1ncoc1-c1ccc2nnc(C3CCC3)n2c1 InChI=1S/C19H15FN4O/c20-15-7-4-12(5-8-15)17-18(25-11-21-17)14-6-9-16-22-23-19(24(16)10-14)13-2-1-3-13/h4-11,13H,1-3H2 QFVILCCNFWNYAN-UHFFFAOYSA-N 16374 5-{3-cyclobutyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(4-fluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 45 Mitogen-activated protein kinase 14 Homo sapiens 17.7 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16374&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9945595 46516615 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29660 Fc1ccc(cc1)-c1ncoc1-c1ccc2nnc(C3CC3)n2c1 InChI=1S/C18H13FN4O/c19-14-6-3-11(4-7-14)16-17(24-10-20-16)13-5-8-15-21-22-18(12-1-2-12)23(15)9-13/h3-10,12H,1-2H2 HTRYISKMFSYGKQ-UHFFFAOYSA-N 16375 5-{3-cyclopropyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(4-fluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 46 Mitogen-activated protein kinase 14 Homo sapiens 10.9 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16375 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16375&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9923086 46516616 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29661 CC(C)Cc1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C19H17FN4O/c1-12(2)9-17-23-22-16-8-5-14(10-24(16)17)19-18(21-11-25-19)13-3-6-15(20)7-4-13/h3-8,10-12H,9H2,1-2H3 RJNVODGSRLWSNQ-UHFFFAOYSA-N 16376 4-(4-fluorophenyl)-5-[3-(2-methylpropyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 47 Mitogen-activated protein kinase 14 Homo sapiens 8.8 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16376 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16376&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647332 46516617 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29662 CC(C)Nc1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C18H16FN5O/c1-11(2)21-18-23-22-15-8-5-13(9-24(15)18)17-16(20-10-25-17)12-3-6-14(19)7-4-12/h3-11H,1-2H3,(H,21,23) RRBBBSFEDDLCLG-UHFFFAOYSA-N 16377 6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-N-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-3-amine::triazolopyridine oxazole inhibitor 48 Mitogen-activated protein kinase 14 Homo sapiens 5.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16377 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16377&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647333 46516618 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29663 CCCNc1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C18H16FN5O/c1-2-9-20-18-23-22-15-8-5-13(10-24(15)18)17-16(21-11-25-17)12-3-6-14(19)7-4-12/h3-8,10-11H,2,9H2,1H3,(H,20,23) LGFCNIUZXZRXSB-UHFFFAOYSA-N 16378 6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-N-propyl-[1,2,4]triazolo[3,4-a]pyridin-3-amine::triazolopyridine oxazole inhibitor 49 Mitogen-activated protein kinase 14 Homo sapiens 198 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16378 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16378&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647334 46516619 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29664 CCN(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C18H16FN5O/c1-3-23(2)18-22-21-15-9-6-13(10-24(15)18)17-16(20-11-25-17)12-4-7-14(19)8-5-12/h4-11H,3H2,1-2H3 IDTWBTMCQKAQQB-UHFFFAOYSA-N 16379 N-ethyl-6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-N-methyl-[1,2,4]triazolo[3,4-a]pyridin-3-amine::triazolopyridine oxazole inhibitor 50 Mitogen-activated protein kinase 14 Homo sapiens 4.7 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16379 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16379&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647335 46516620 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29665 CC(C)Oc1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C18H15FN4O2/c1-11(2)25-18-22-21-15-8-5-13(9-23(15)18)17-16(20-10-24-17)12-3-6-14(19)7-4-12/h3-11H,1-2H3 MJYLXFFGAPFRNQ-UHFFFAOYSA-N 16380 4-(4-fluorophenyl)-5-[3-(propan-2-yloxy)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 51 Mitogen-activated protein kinase 14 Homo sapiens 17.9 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16380&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647336 46516621 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29666 CC1(CCC1)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C20H17FN4O/c1-20(9-2-10-20)19-24-23-16-8-5-14(11-25(16)19)18-17(22-12-26-18)13-3-6-15(21)7-4-13/h3-8,11-12H,2,9-10H2,1H3 KAUMAIMTDFWYJZ-UHFFFAOYSA-N 16381 4-(4-fluorophenyl)-5-[3-(1-methylcyclobutyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 52 Mitogen-activated protein kinase 14 Homo sapiens 14.0 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16381 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16381&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647337 46516622 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29667 Fc1ccc(cc1)-c1ncoc1-c1ccc2nnc(N3CCCC3)n2c1 InChI=1S/C19H16FN5O/c20-15-6-3-13(4-7-15)17-18(26-12-21-17)14-5-8-16-22-23-19(25(16)11-14)24-9-1-2-10-24/h3-8,11-12H,1-2,9-10H2 JKSVPILHZOTLQD-UHFFFAOYSA-N 16382 4-(4-fluorophenyl)-5-[3-(pyrrolidin-1-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 53 Mitogen-activated protein kinase 14 Homo sapiens 15.4 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16382 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16382&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647338 46516623 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29668 Fc1ccc(cc1)-c1ncoc1-c1ccc2nnc(-c3ccccc3)n2c1 InChI=1S/C21H13FN4O/c22-17-9-6-14(7-10-17)19-20(27-13-23-19)16-8-11-18-24-25-21(26(18)12-16)15-4-2-1-3-5-15/h1-13H QCJWBKMIGDTPMY-UHFFFAOYSA-N 16383 4-(4-fluorophenyl)-5-{3-phenyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-1,3-oxazole::triazolopyridine oxazole inhibitor 54 Mitogen-activated protein kinase 14 Homo sapiens 12.3 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16383 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16383&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9968604 46516624 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29669 COc1ccccc1-c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C22H15FN4O2/c1-28-18-5-3-2-4-17(18)22-26-25-19-11-8-15(12-27(19)22)21-20(24-13-29-21)14-6-9-16(23)10-7-14/h2-13H,1H3 DTVJMDGVZOSSLI-UHFFFAOYSA-N 16384 4-(4-fluorophenyl)-5-[3-(2-methoxyphenyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 55 Mitogen-activated protein kinase 14 Homo sapiens 0.4 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16384 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16384&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647339 46516625 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29670 CCOc1ccccc1-c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C23H17FN4O2/c1-2-29-19-6-4-3-5-18(19)23-27-26-20-12-9-16(13-28(20)23)22-21(25-14-30-22)15-7-10-17(24)11-8-15/h3-14H,2H2,1H3 XYWQAMREXZFVOE-UHFFFAOYSA-N 16385 5-[3-(2-ethoxyphenyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-(4-fluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 56 Mitogen-activated protein kinase 14 Homo sapiens 0.4 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16385 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16385&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647340 46516626 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29671 CC(C)(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1 InChI=1S/C19H17FN4O/c1-19(2,3)18-23-22-15-9-6-13(10-24(15)18)17-16(21-11-25-17)12-4-7-14(20)8-5-12/h4-11H,1-3H3 ZDAGVFUZAHXRQK-UHFFFAOYSA-N 16386 5-{3-tert-butyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(4-fluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 57 Mitogen-activated protein kinase 14 Homo sapiens 3.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16386 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16386&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647341 46516627 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29672 Fc1ccc(cc1)-c1ncoc1-c1ccc2nnc(N3CCOCC3)n2c1 InChI=1S/C19H16FN5O2/c20-15-4-1-13(2-5-15)17-18(27-12-21-17)14-3-6-16-22-23-19(25(16)11-14)24-7-9-26-10-8-24/h1-6,11-12H,7-10H2 LMYKNINLHCJDHE-UHFFFAOYSA-N 16387 4-{6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-[1,2,4]triazolo[3,4-a]pyridin-3-yl}morpholine::triazolopyridine oxazole inhibitor 58 Mitogen-activated protein kinase 14 Homo sapiens 11.8 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16387 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16387&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647342 46516628 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29673 Fc1ccc(cc1)-c1ncoc1-c1ccc2nnc(Cc3ccccc3)n2c1 InChI=1S/C22H15FN4O/c23-18-9-6-16(7-10-18)21-22(28-14-24-21)17-8-11-19-25-26-20(27(19)13-17)12-15-4-2-1-3-5-15/h1-11,13-14H,12H2 RASWNQHJQMMLNH-UHFFFAOYSA-N 16388 5-{3-benzyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(4-fluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 59 Mitogen-activated protein kinase 14 Homo sapiens 19.9 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16388 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16388&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647343 46516629 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29674 Fc1ccc(-c2ncoc2-c2ccc3nnc(C4CC4)n3c2)c(F)c1 InChI=1S/C18H12F2N4O/c19-12-4-5-13(14(20)7-12)16-17(25-9-21-16)11-3-6-15-22-23-18(10-1-2-10)24(15)8-11/h3-10H,1-2H2 UPOFEOMEMGQTJA-UHFFFAOYSA-N 16389 5-{3-cyclopropyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,4-difluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 60 Mitogen-activated protein kinase 14 Homo sapiens 3.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16389 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16389&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10382478 46516630 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29675 CC1(CC1)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1F InChI=1S/C19H14F2N4O/c1-19(6-7-19)18-24-23-15-5-2-11(9-25(15)18)17-16(22-10-26-17)13-4-3-12(20)8-14(13)21/h2-5,8-10H,6-7H2,1H3 ZBSUTYBJWPJEPR-UHFFFAOYSA-N 16390 4-(2,4-difluorophenyl)-5-[3-(1-methylcyclopropyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 61 Mitogen-activated protein kinase 14 Homo sapiens 0.7 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16390 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16390&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9975266 46516631 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29676 Fc1ccc(-c2ncoc2-c2ccc3nnc(C4CCC4)n3c2)c(F)c1 InChI=1S/C19H14F2N4O/c20-13-5-6-14(15(21)8-13)17-18(26-10-22-17)12-4-7-16-23-24-19(25(16)9-12)11-2-1-3-11/h4-11H,1-3H2 VZTJNVJKEKIGHC-UHFFFAOYSA-N 16391 5-{3-cyclobutyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,4-difluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 62 Mitogen-activated protein kinase 14 Homo sapiens 3.75 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16391 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16391&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647344 46516632 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29677 CC1(CCC1)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1F InChI=1S/C20H16F2N4O/c1-20(7-2-8-20)19-25-24-16-6-3-12(10-26(16)19)18-17(23-11-27-18)14-5-4-13(21)9-15(14)22/h3-6,9-11H,2,7-8H2,1H3 PMDHDZWNKZXXHZ-UHFFFAOYSA-N 16392 4-(2,4-difluorophenyl)-5-[3-(1-methylcyclobutyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 63 Mitogen-activated protein kinase 14 Homo sapiens 1.1 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16392 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16392&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647345 46516633 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29678 CC(C)(C)c1nnc2ccc(cn12)-c1ocnc1-c1ccc(F)cc1F InChI=1S/C19H16F2N4O/c1-19(2,3)18-24-23-15-7-4-11(9-25(15)18)17-16(22-10-26-17)13-6-5-12(20)8-14(13)21/h4-10H,1-3H3 XTZMVZVCDOJUJH-UHFFFAOYSA-N 16393 5-{3-tert-butyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,4-difluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 64 Mitogen-activated protein kinase 14 Homo sapiens 1.1 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16393 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16393&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10247543 46516634 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29679 CC(C)(O)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)ccc1F InChI=1S/C18H14F2N4O2/c1-18(2,25)17-23-22-14-6-3-10(8-24(14)17)16-15(21-9-26-16)12-7-11(19)4-5-13(12)20/h3-9,25H,1-2H3 AYBYGYLAVPCWLE-UHFFFAOYSA-N 16394 2-{6-[4-(2,5-difluorophenyl)-1,3-oxazol-5-yl]-[1,2,4]triazolo[3,4-a]pyridin-3-yl}propan-2-ol::triazolopyridine oxazole inhibitor 65 Mitogen-activated protein kinase 14 Homo sapiens 25 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16394 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16394&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23644699 46509503 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29680 Fc1ccc(F)c(c1)-c1ncoc1-c1ccc2nnc(C3CC3)n2c1 InChI=1S/C18H12F2N4O/c19-12-4-5-14(20)13(7-12)16-17(25-9-21-16)11-3-6-15-22-23-18(10-1-2-10)24(15)8-11/h3-10H,1-2H2 ZYQDWWHVGBPWCI-UHFFFAOYSA-N 16395 5-{3-cyclopropyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,5-difluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 66 Mitogen-activated protein kinase 14 Homo sapiens 24 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16395 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16395&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10337188 46516635 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29681 CC1(CC1)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)ccc1F InChI=1S/C19H14F2N4O/c1-19(6-7-19)18-24-23-15-5-2-11(9-25(15)18)17-16(22-10-26-17)13-8-12(20)3-4-14(13)21/h2-5,8-10H,6-7H2,1H3 FDYFXQHQKJEWQH-UHFFFAOYSA-N 16396 4-(2,5-difluorophenyl)-5-[3-(1-methylcyclopropyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 67 Mitogen-activated protein kinase 14 Homo sapiens 3.0 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16396 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16396&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10089343 46516636 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29682 Fc1ccc(F)c(c1)-c1ncoc1-c1ccc2nnc(C3CCC3)n2c1 InChI=1S/C19H14F2N4O/c20-13-5-6-15(21)14(8-13)17-18(26-10-22-17)12-4-7-16-23-24-19(25(16)9-12)11-2-1-3-11/h4-11H,1-3H2 VNHGSIKXBJYVIS-UHFFFAOYSA-N 16397 5-{3-cyclobutyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,5-difluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 68 Mitogen-activated protein kinase 14 Homo sapiens 9.7 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16397 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16397&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10247424 46516637 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29683 CC1(CCC1)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)ccc1F InChI=1S/C20H16F2N4O/c1-20(7-2-8-20)19-25-24-16-6-3-12(10-26(16)19)18-17(23-11-27-18)14-9-13(21)4-5-15(14)22/h3-6,9-11H,2,7-8H2,1H3 GJTSFEDWYSEVOG-UHFFFAOYSA-N 16398 4-(2,5-difluorophenyl)-5-[3-(1-methylcyclobutyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,3-oxazole::triazolopyridine oxazole inhibitor 69 Mitogen-activated protein kinase 14 Homo sapiens 1.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16398&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647346 46516638 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29684 CC(C)(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)ccc1F InChI=1S/C19H16F2N4O/c1-19(2,3)18-24-23-15-7-4-11(9-25(15)18)17-16(22-10-26-17)13-8-12(20)5-6-14(13)21/h4-10H,1-3H3 APLXMOMMUKPMLH-UHFFFAOYSA-N 16399 5-{3-tert-butyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,5-difluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 70 Mitogen-activated protein kinase 14 Homo sapiens 8.8 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16399 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16399&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10316101 46516639 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29685 Fc1cc(F)c(cc1F)-c1ncoc1-c1ccc2nnc(C3CC3)n2c1 InChI=1S/C18H11F3N4O/c19-12-6-14(21)13(20)5-11(12)16-17(26-8-22-16)10-3-4-15-23-24-18(9-1-2-9)25(15)7-10/h3-9H,1-2H2 FQYLLZWNUOSCFS-UHFFFAOYSA-N 16400 5-{3-cyclopropyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,4,5-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 71 Mitogen-activated protein kinase 14 Homo sapiens 7.8 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16400 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16400&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9906682 46516640 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29686 CC1(CC1)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)c(F)cc1F InChI=1S/C19H13F3N4O/c1-19(4-5-19)18-25-24-15-3-2-10(8-26(15)18)17-16(23-9-27-17)11-6-13(21)14(22)7-12(11)20/h2-3,6-9H,4-5H2,1H3 JOHOCXWBNVWZSY-UHFFFAOYSA-N 16401 5-[3-(1-methylcyclopropyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-(2,4,5-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 72 Mitogen-activated protein kinase 14 Homo sapiens 2.3 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16401 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16401&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 10384508 46516641 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29687 Fc1cc(F)c(cc1F)-c1ncoc1-c1ccc2nnc(C3CCC3)n2c1 InChI=1S/C19H13F3N4O/c20-13-7-15(22)14(21)6-12(13)17-18(27-9-23-17)11-4-5-16-24-25-19(26(16)8-11)10-2-1-3-10/h4-10H,1-3H2 LNRILYJJWLNTQP-UHFFFAOYSA-N 16402 5-{3-cyclobutyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,4,5-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 73 Mitogen-activated protein kinase 14 Homo sapiens 9.1 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16402 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16402&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 22242056 46516642 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29688 CC1(CCC1)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)c(F)cc1F InChI=1S/C20H15F3N4O/c1-20(5-2-6-20)19-26-25-16-4-3-11(9-27(16)19)18-17(24-10-28-18)12-7-14(22)15(23)8-13(12)21/h3-4,7-10H,2,5-6H2,1H3 PWWIHBOBIJUPSU-UHFFFAOYSA-N 16403 5-[3-(1-methylcyclobutyl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-4-(2,4,5-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 74 Mitogen-activated protein kinase 14 Homo sapiens 2.5 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16403 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16403&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647347 46516643 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29689 CC(C)(C)c1nnc2ccc(cn12)-c1ocnc1-c1cc(F)c(F)cc1F InChI=1S/C19H15F3N4O/c1-19(2,3)18-25-24-15-5-4-10(8-26(15)18)17-16(23-9-27-17)11-6-13(21)14(22)7-12(11)20/h4-9H,1-3H3 VNZJNPIWZYMGAO-UHFFFAOYSA-N 16404 5-{3-tert-butyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl}-4-(2,4,5-trifluorophenyl)-1,3-oxazole::triazolopyridine oxazole inhibitor 75 Mitogen-activated protein kinase 14 Homo sapiens 1.8 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16404 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16404&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 9999342 46516644 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29690 CC(C)c1nnc2ccc(cn12)-c1c[nH]nc1-c1cc(F)ccc1F InChI=1S/C18H15F2N5/c1-10(2)18-24-22-16-6-3-11(9-25(16)18)14-8-21-23-17(14)13-7-12(19)4-5-15(13)20/h3-10H,1-2H3,(H,21,23) XQFBFBBFUGBKRH-UHFFFAOYSA-N 16405 3-(2,5-difluorophenyl)-4-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1H-pyrazole::pyrazole 79 Mitogen-activated protein kinase 14 Homo sapiens 2.8 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16405 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16405&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647348 46516645 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29691 CC(C)c1nnc2ccc(cn12)-c1cnoc1-c1cc(F)ccc1F InChI=1S/C18H14F2N4O/c1-10(2)18-23-22-16-6-3-11(9-24(16)18)14-8-21-25-17(14)13-7-12(19)4-5-15(13)20/h3-10H,1-2H3 BMAFABSRVLXVFC-UHFFFAOYSA-N 16406 5-(2,5-difluorophenyl)-4-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1,2-oxazole::isoxazole 80 Mitogen-activated protein kinase 14 Homo sapiens 33.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16406&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647349 46516646 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 29692 CC(C)c1nnc2ccc(cn12)-c1nc[nH]c1-c1cc(F)ccc1F InChI=1S/C18H15F2N5/c1-10(2)18-24-23-15-6-3-11(8-25(15)18)16-17(22-9-21-16)13-7-12(19)4-5-14(13)20/h3-10H,1-2H3,(H,21,22) UIQOOHLUHZGTBA-UHFFFAOYSA-N 16407 4-(2,5-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6-yl]-1H-imidazole::imidazole 81 Mitogen-activated protein kinase 14 Homo sapiens 6.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2006.05.056 10.7270/Q2251GFZ 16759861 aid1797498 McClure, KF; Letavic, MA; Kalgutkar, AS; Gabel, CA; Audoly, L; Barberia, JT; Braganza, JF; Carter, D; Carty, TJ; Cortina, SR; Dombroski, MA; Donahue, KM; Elliott, NC; Gibbons, CP; Jordan, CK; Kuperman, AV; Labasi, JM; Laliberte, RE; McCoy, JM; Naiman, BM; Nelson, KL; Nguyen, HT; Peese, KM; Sweeney, FJ; Taylor, TJ; Trebino, CE; Abramov, YA; Laird, ER; Volberg, WA; Zhou, J; Bach, J; Lombardo, F 8/15/2006 7/2/2007 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16407 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16407&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 23647350 46516647 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 3ZYA,3U8W,3LHJ,3ITZ,3GFE,3FC1,3DS6,2ONL,2OKR,1YQJ,1WFC,1R39,1OUY,1OUK,1M7Q,6ZQS,6TCA,6QE1,6QDZ,5ETC,3K3J,3HA8,2EWA,1BL7,1BL6,1A9U,9O4L,9NYT,9CJ5,9CJ4,9CJ3,9CJ2,9CJ1,8YD9,5XYY,5XYX,5TBE,5OMH,5OMG,5N68,5N67,5N66,5N65,5N64,5N63,5MTY,5MTX,5ML5,5ETA,4E8A,4E6C,4E6A,4E5B,3ROC,3RIN,3MGY,3KQ7,3KF7,3IPH,3HP5,3HP2,3HLL,3HL7,3DT1,3D83,3D7Z,2ZB1,2ZB0,2ZAZ,1ZZ2,1ZYJ,1WBW,1WBV,1WBT,1WBS,1WBO,1WBN,1W84,1W83,1W82,1W7H,1KV2,1KV1,1DI9,3MPT,3HVC,3E93,3E92,8X3M,3FSK,3FSF,3FMN,3FMM,3FML,3FMK,3FMJ,3FMH,3FLZ,3FLY,3FLW,3FLS,3FLQ,3FL4,3FKN,3FKL,2GFS,1OZ1,9MHB,6HWV,6HWU,6HWT,5TCO,4ZTH,4R3C,4L8M,4FA2,4F9Y,4F9W,4EWQ,4EHV,4EH9,4EH8,4EH7,4EH6,4EH5,4EH4,4EH3,4EH2,4DLJ,4DLI,3ZSI,3ZSH,3ZSG,3ZS5,3UVR,3UVQ,3UVP,3QUE,3QUD,3MW1,3LFA,3HV7,3HV6,3HV5,3HV4,3HUC,3HRB,3GCU,2YIW,2YIS,4KIQ,4KIP,4KIN,4AAC,4AA5,4AA4,4AA0,4A9Y,3S4Q,3OCG,3NWW,3MVM,3MVL,3L8X,3C5U,3BX5,3BV3,3BV2,2RG6,2RG5,2QD9,2BAL,2BAK,2BAJ,1IAN,2NPQ,8VXE,3NNX,3NNW,3NNV,3NNU,2LGC,2YIX,1ZZL,3S3I,3HEG,3HEC,3K3I Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0